Cargando…
Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015()
There are more vaccines in development, against a greater number of pathogens, than ever before. A challenge with this exceptional level of activity and investment is how to select and resource the most promising approaches to have the most significant impact on public health. The WHO Product Develo...
Autores principales: | Giersing, Birgitte K., Modjarrad, Kayvon, Kaslow, David C., Moorthy, Vasee S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization; licensee Elsevier Ltd.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130468/ https://www.ncbi.nlm.nih.gov/pubmed/26993336 http://dx.doi.org/10.1016/j.vaccine.2016.02.078 |
Ejemplares similares
-
Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016
por: Giersing, Birgitte K., et al.
Publicado: (2019) -
WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
por: Modjarrad, Kayvon, et al.
Publicado: (2016) -
A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation
por: Modjarrad, Kayvon, et al.
Publicado: (2016) -
Advisory Committee of CERN Users - 99th Meeting
Publicado: (2013) -
Advisory Committee of CERN Users (ACCU): Minutes of the 107th Meeting held on 10th March 2015
por: Hauschild, Michael
Publicado: (2015)